<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0045503</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1920</journal-id>
<journal-id journal-id-type="nlm-ta">Brain Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Res.</journal-id>
<journal-title-group>
<journal-title>Brain research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8993</issn>
<issn pub-type="epub">1872-6240</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26854137</article-id>
<article-id pub-id-type="pmc">4975680</article-id>
<article-id pub-id-type="doi">10.1016/j.brainres.2016.01.057</article-id>
<article-id pub-id-type="manuscript">NIHMS759826</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling autism spectrum disorders with human neurons</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Beltrão-Braga</surname>
<given-names>Patricia C B</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muotri</surname>
<given-names>Alysson R</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Center for Cellular and Molecular Therapy (NETCEM), School of Medicine, University of São Paulo, São Paulo, Brazil</aff>
<aff id="A2"><label>b</label>Department of Pediatrics/Rady Children’s Hospital San Diego, Department of Cellular &amp; Molecular Medicine, Stem Cell Program, School of Medicine, University of California San Diego, La Jolla, CA, USA</aff>
<aff id="A3"><label>c</label>Stem Cell Laboratory, Department of Surgery, School of Veterinary Medicine, University of São Paulo, São Paulo, Brazil</aff>
<aff id="A4"><label>d</label>Department of Obstetrics School of Arts, Sciences and Humanities, University of São Paulo, São Paulo, Brazil</aff>
<author-notes>
<corresp id="FN1"><label>*</label>To whom correspondence should be addressed: Dr. Patricia Beltrão-Braga, University of São Paulo, School of Arts, Sciences and Humanities, 1000 Arllindo Bettio Av, 03828-000, São Paulo, Brazil and Dr. Alysson Renato Muotri, University of California San Diego, School of Medicine, Department of Pediatrics/Rady Children’s Hospital San Diego, Department of Cellular &amp; Molecular Medicine, Stem Cell Program, La Jolla, CA 92093, MC 0695, USA. <email>patriciacbbbraga@usp.br</email> and <email>muotri@ucsd.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>1656</volume>
<fpage>49</fpage>
<lpage>54</lpage>
<!--elocation-id from pubmed: 10.1016/j.brainres.2016.01.057-->
<abstract>
<p id="P2">Autism Spectrum Disorder (ASD) is a group of neurodevelopmental disorders characterized by impaired social communication and interactions and by restricted and repetitive behaviors. Although ASD is suspected to have a heritable or sporadic genetic basis, its underlying etiology and pathogenesis are not well understood. Therefore, viable human neurons and glial cells produced using induced pluripotent stem cells (iPSC) to reprogram cells from individuals affected with ASD provide an unprecedented opportunity to elucidate the pathophysiology of these disorders, providing novel insights regarding ASD and a potential platform to develop and test therapeutic compounds. Herein, we discuss the state of art with regards to ASD modeling, including limitations of this technology, as well as potential future directions.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorders</kwd>
<kwd>disease modeling</kwd>
<kwd>human induced pluripotent stem cells</kwd>
<kwd>human neurons</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>